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Abstract
Background: The World Health Organization (WHO), like many other organisations around the world, has recognised
the need to use more rigorous processes to ensure that health care recommendations are informed by the best available
research evidence. This is the second of a series of 16 reviews that have been prepared as background for advice from
the WHO Advisory Committee on Health Research to WHO on how to achieve this.
Objectives: We reviewed the literature on priority setting for health care guidelines, recommendations and technology
assessments.
Methods: We searched PubMed and three databases of methodological studies for existing systematic reviews and
relevant methodological research. We did not conduct systematic reviews ourselves. Our conclusions are based on the
available evidence, consideration of what WHO and other organisations are doing and logical arguments.
Key questions and answers: There is little empirical evidence to guide the choice of criteria and processes for
establishing priorities, but there are broad similarities in the criteria that are used by various organisations and practical
arguments for setting priorities explicitly rather than implicitly,
What criteria should be used to establish priorities?: • WHO has limited resources and capacity to develop
recommendations. It should use these resources where it has the greatest chance of improving health, equity, and
efficient use of healthcare resources.
• We suggest the following criteria for establishing priorities for developing recommendations based on WHO's aims
and strategic advantages:
• Problems associated with a high burden of illness in low and middle-income countries, or new and emerging diseases.
• No existing recommendations of good quality.
• The feasibility of developing recommendations that will improve health outcomes, reduce inequities or reduce
unnecessary costs if they are implemented.
• Implementation is feasible, will not exhaustively use available resources, and barriers to change are not likely to be so
high that they cannot be overcome.
• Additional priorities for WHO include interventions that will likely require system changes and interventions where
there might be a conflict in choices between individual and societal perspectives.
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What processes should be used to agree on priorities?: • The allocation of resources to the development of
recommendations should be part of the routine budgeting process rather than a separate exercise.
• Criteria for establishing priorities should be applied using a systematic and transparent process.
• Because data to inform judgements are often lacking, unmeasured factors should also be considered – explicitly and
transparently.
• The process should include consultation with potential end users and other stakeholders, including the public, using
well-constructed questions, and possibly using Delphi-like procedures.
• Groups that include stakeholders and people with relevant types of expertise should make decisions. Group processes
should ensure full participation by all members of the group.
• The process used to select topics should be documented and open to inspection.
Should WHO have a centralised or decentralised process?: • Both centralised and decentralised processes
should be used. Decentralised processes can be considered as separate "tracks".
• Separate tracks should be used for considering issues for specific areas, populations, conditions or concerns. The
rationales for designating special tracks should be defined clearly; i.e. why they warrant special consideration.
• Updating of guidelines could also be considered as a separate "track", taking account of issues such as the need for 
corrections and the availability of new evidence.
Background
The World Health Organization (WHO), like many other
organisations around the world, has recognised the need
to use more rigorous processes to ensure that health care
recommendations are informed by the best available
research evidence. This is the second of a series of 16
reviews that have been prepared as background for advice
from the WHO Advisory Committee on Health Research
to WHO on how to achieve this. In this paper we address
the following questions:
• What criteria should be used to establish priorities?
• What processes should be used to agree on priorities?
• Should WHO have a centralised or decentralised proc-
ess?
Questions related to group processes for committees
developing guidelines and recommendations and priority
setting for systematic reviews are addressed in other
papers in this series [1,2].
What WHO is doing now
WHO does not have a centralised process specifically for
setting priorities for the development of recommenda-
tions. A report of the Director-General to the Executive
Board on WHO's strategic budgeting and planning proc-
ess had this to say about priority setting in general (with-
out specific reference to priorities for recommendations):
Specific global priorities were included in the procedural guid-
ance for 2002–2003, and measures were provided to ensure a
shift of resources to those areas. With regard to regional and
country health issues, the team received diverging views. Some
staff expressed concern about the little room for specific regional
or country priorities, which would not relate directly to the glo-
bal priorities. Others expressed the need for flexibility during
the operational planning phase, which should contribute to the
achievement of global priorities in terms of reducing a health
problem or improving the health status of the population. It is
important to create a monitoring and evaluation system, in
which such flexibility can be taken into account.
The report offered these two recommendations regarding
priority setting in general:
Criteria and parameters for rationalizing the setting of pro-
gramme priorities should be re-examined with the view to
achieving more objectivity.
Exercises to shift resources to priority areas should be an inte-
gral part of the programme budgeting process, and not taken up
as a separate exercise.
The Guidelines for WHO Guidelines recommends the fol-
lowing [3]:
Guideline development is a process which consumes resources
(see Sec VII). They could be developed on almost every health
topic or intervention so it is necessary for WHO to decide which
topics should be given priority. It is suggested that the following
areas be given priority:
¾
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interventions that will require system changes (feasibility
concerns) as opposed to those dealing solely with provider/
patient interactions. WHO has greater comparative advantage
in dealing with governments, for interventions which require
inputs and coordination at different levels of the system. It has
less comparative advantage on purely provider/patient interac-
tions.
cost-effective interventions that address a disease burden
which is still causing major health losses, implying under-utili-
zation of the technology (population perspective).
interventions that are of limited or questionable effectiveness
but are being used widely (opportunity costs).
Interventions for diseases which have a high burden in devel-
oping countries, or new and emerging diseases for which there
are no existing guidelines.
interventions where there might possibly be a conflict in
choices between individual and societal perspectives (political
concerns: when countries will need WHO's normative support
to make recommendations based on the population perspective
especially in the context of other influential organizations
espousing guidelines adopting an individual perspective).
The Health Evidence Network (HEN), based at the Euro-
pean Regional Office of WHO [4], collects policy concerns
and questions from several sources and through both a proactive
and a reactive approach:
Proactive:
1. Call for topics once a year, through a simple and user-
friendly questionnaire to Ministries of Health of Members
States, WHO technical units (TUs) including European
observatory for Health care systems
2. Reviewing the work already done by HEN Members as well
as their work in progress
3. Review of minutes of EU' Parliament
Reactive:
1. The Health Evidence Network To the HEN e-mailbox or
direct requests from policymakers
2. Specific questions or policy concerns identified by the Observ-
atory or WHO Technical Units in their processes of production
of papers.
Once collected, all this information is translated by the HEN
team into answerable questions. The list of questions is then
presented to the Steering Committee once a year for its prioriti-
zation according to policy relevance, feasibility, timelines, con-
troversy, existing evidence.
What other organisations are doing
About 30% of respondents to an international survey of
producers of clinical practice guidelines or health technol-
ogy assessments reported using explicit methods of setting
priorities, including the use of explicit criteria, formal con-
sensus processes, and burden of disease [4]. The US Com-
munity Preventive Services Task Force, for example,
chooses broad topics (e.g., tobacco use, cancer, diabetes, the
social environment) for review on the basis of the public health
burden of the problem; how preventable it is; how it relates to
other public health initiatives; and the current level of research
and practice activity in public health, clinical, and other set-
tings. The agenda-setting process incorporates input from inter-
ested others.
The process of selecting specific interventions for review within
those topics involves developing a candidate list of interven-
tions, and setting priorities using a voting procedure among the
team and the consultants. The Task Force approves or modifies
the resulting priorities. Priority-setting criteria that are adapted
for the reviews include perceived potential to reduce the burden
of disease and injury; potential to increase healthy behaviors
and reduce unhealthy behaviors; potential to increase the
implementation of effective but not widely used interventions;
potential to phase out widely used, less effective interventions in
favor of more effective or more cost-effective options; and cur-
rent level of interest among providers and decision makers.
Other priority-setting criteria may be added as relevant and
appropriate. Occasionally, review teams have engaged in for-
mal scoring and weighting of the criteria. One or more rounds
of this process results in a prioritized list of interventions.
Other respondents to the survey reported selecting topics
based on consultations with their constituencies, requests
from end-users, or decisions made by expert panels or a
steering group without explicit methods. Seventeen of 67
respondents (25%) reported involving target users in the
groups that set priorities.
Methods
The methods used to prepare this review are described in
the introduction to this series [5]. Briefly, the key ques-
tions addressed in this paper were vetted amongst the
authors and the ACHR Subcommittee on the Use of
Research Evidence (SURE). We did not conduct a full sys-
tematic review. We searched PubMed and three databases
of methodological studies (the Cochrane Methodology
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and the Guidelines International Network [8]) for existing
systematic reviews and relevant methodological research
that address these questions. The answers to the questions
are our conclusions based on the available evidence, con-
sideration of what WHO and other organisations are
doing, and logical arguments.
For this review we searched PubMed using (clinical prac-
tice guidelines or public health guidelines) and (priority
setting or setting priorities) and related articles for selected
references [9,10]. We searched the Cochrane Methodol-
ogy Register using priority or priorities. We reviewed the
website of the 5th International Conference on Priorities
in Health Care [11] and references that we had in our files
[12-15].
Findings
What criteria should be used to establish priorities?
The US Institute of Medicine's (IOM) Committee on
Methods for Setting Priorities for Guidelines Develop-
ment in its study of setting priorities for clinical practice
guidelines published in 1995 argued that the priority set-
ting process should be open and defensible [14] They rec-
ommended six general criteria: prevalence, burden of
illness, cost of managing the problem, variability in prac-
tice, potential of a guideline to improve health outcomes,
and potential of a guideline to reduce costs. Because data
used to make these judgements is often lacking, they sug-
gested explicit opportunities for important unmeasured
factors to be considered. They further suggested separate
"tracks" for considering issues for specific populations,
conditions or concerns. They argued that the rationales for
designating special tracks should be defined clearly; i.e.
why they warrant special consideration. They suggested
that updating of guidelines should also be considered as a
separate "track", taking account of issues such as the need
for corrections and the availability of new evidence.
Oortwijn identified 25 criteria used to prioritise health
technology assessments and categorised these into four
broad categories: burden of disease, potential effects,
potential costs, and uncertainty regarding application of
the technology [15].
In a more recent selective review for the New Zealand
Guidelines Group, the following criteria were identified as
indicating that a topic is suitable for guideline develop-
ment [16]:
1. The topic is clinically important affecting large numbers of
people with substantial morbidity or mortality (the burden of
illness).
2. The topic is complex enough to initiate debate about the rec-
ommendations.
3. There is evidence of variation between actual and appropri-
ate care.
4. There are no existing valid guidelines available to use.
5. There is an adequate amount of existing evidence available.
6. The recommendations will be acceptable to the potential
users.
7. Implementation of the guideline is feasible, will not exhaus-
tively use the communities' resources, and barriers to clinical
change are not so high that they cannot be overcome.
While burden of disease is commonly used as a criterion
for priority setting, it should be noted that the use of sum-
mary burden of disease measures, such as disability
adjusted life years (DALYs) has been criticised for focusing
on disease rather than resource use and interventions,
because of the assumptions about values inherent in such
measures, and because of the technical limitations of such
measures (see for example references [17] and [18]).
What processes should be used to agree on priorities?
Batista and Hodge in a review conducted 10 years ago
found only three articles pertinent to priority setting for
clinical practice guidelines [10]. They suggested the fol-
lowing framework for priority setting:
1. Consult with end users and other stakeholders before
selecting topics.
2. Consider feasibility during the consultation.
3. Document the process used to select guideline topics.
The IOM suggested the following procedures [14]:
• the use of Delphi-like procedures for obtaining expert
judgments or topic rankings through correspondence
• the use of questions that are specific, explicit and con-
sistent with standard methods for questionnaire construc-
tion
• experimentation with more formal procedures to arrive
at group judgments
They also suggested there is a need to define more nar-
rowly and precisely topics for guideline development.
They argued that this would result in more efficient organ-
ization of panels and their work, resolution of some
apparent controversies, more responsive guidelines, and
easier implementation.Health Research Policy and Systems 2006, 4:14 http://www.health-policy-systems.com/content/4/1/14
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Oortwijn identified six steps in the development of prac-
tical procedures for setting priorities [15]:
1. Clarifying goals and responsibilities:
2. Choosing a general approach, method, and criteria for prior-
itisation;
3. Establishing advisory mechanisms and relations with exter-
nal bodies;
4. Establishing arrangements to support and manage the proce-
dure;
5. Defining a time table and cycle of activity; and
6. Evaluating and developing the procedure.
She further identified the following ways in which
approaches to priority setting can vary:
• the extent to which the procedure is explicit and systematic
• the extent to which external input and advice is accepted or
actively sought
• the relative weight given to the views of decision-makers,
researchers, and others
• the extent to which the procedure is transparent
• the effort and resources devoted to the procedure
Her main conclusion was that explicit and transparent pri-
ority setting for health technology assessment is feasible,
but that some important methodological issues need to
be addressed to ensure that the procedure used is valid,
reliable, consistent and useful for policy making.
There is some debate, variation in practice, and limited
data regarding involvement of the public in priority set-
ting. There is limited evidence from a small survey in Aus-
tralia that the public overwhelmingly want their
preferences to inform priority-setting decisions [19].
Should WHO have a centralised or decentralised process?
There are two ways in which priority setting is currently
decentralised: geographically (across headquarters,
regional offices and countries), and across technical
departments. There are limited findings in the literature to
inform decisions about how this might best be handled.
The IOM noted, "that it is unreasonable – indeed impos-
sible – to expect nationally developed guidelines to cover
every operational issue for every kind of setting". "Yet
guidelines that leave too much to be decided at the local
level or during implementation run the risk of being
ignored, misused, and modified in ways detrimental to
patients." This is even more so for internationally devel-
oped guidelines. Priority setting at each level should draw
on the strengths and minimize the limitations of interna-
tional, national and local organizations. Thus, both cen-
tralised and decentralised processes that take account of
these different strengths and limitations, as well as needs,
are necessary.
Discussion
WHO has limited resources and limited technical capacity
for developing recommendations. It is essential that it
should set priorities for how best to use the resources and
capacity it has. We did not find an empirical basis for
deciding how best to set priorities. However, the use of
explicit criteria and systematic processes are more likely
than implicit criteria and non-systematic processes to
ensure open and defensible priority setting. Based on the
experience of other organisations, logic and the aims and
strategic advantages of WHO we suggest that the follow-
ing criteria should be used to set priorities:
• Problems associated with a high burden of illness in low
and middle-income countries, or new and emerging dis-
eases.
• No existing guidelines or recommendations of good
quality.
• The feasibility of developing recommendations that will
improve health outcomes, reduce inequities or reduce
unnecessary costs if they are implemented.
• Implementation is feasible, will not exhaustively use
available resources, and barriers to change are not likely to
be so high that they cannot be overcome.
• Additional priorities for WHO include interventions
that will likely require system changes and interventions
where there might be a conflict in choices between indi-
vidual and societal perspectives.
The application of these criteria requires judgements.
Appropriate processes are needed, in addition to explicit
criteria, to ensure that these judgements are made openly,
that they are taken account of in how WHO uses its
resources, and that they reflect the priorities of WHO's
member states, particularly those of low and middle-
income countries. We suggest that the following processes
be used for these reasons:
• The allocation of resources to the development of rec-
ommendations should be part of the routine budgeting
process rather than a separate exercise.Health Research Policy and Systems 2006, 4:14 http://www.health-policy-systems.com/content/4/1/14
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• Criteria for establishing priorities should be applied
using a systematic and transparent process.
• Because data to inform judgements are often lacking,
unmeasured factors should also be considered – explicitly
and transparently.
• The process should include consultation with potential
end users and other stakeholders, including the public,
using well-constructed questions, and possibly using Del-
phi-like procedures.
• Groups that include stakeholders and people with rele-
vant types of expertise should make decisions. Group
processes should ensure full participation by all members
of the group.
• The process used to select topics should be documented
and open to inspection.
Both centralised and decentralised processes should be
used to take account of different strengths, limitations and
needs within WHO across headquarters, regions and
countries; and across different technical areas. Drawing on
the suggestion of the IOM for having different tracks for
considering issues for specific populations, conditions or
concerns [14], we suggest:
• Both centralised and decentralised processes should be
used. Decentralised processes can be considered as sepa-
rate "tracks".
• Separate tracks should be used for considering issues for
specific areas, populations, conditions or concerns. The
rationales for designating special tracks should be defined
clearly; i.e. why they warrant special consideration.
• Updating of guidelines could also be considered as a
separate "track", taking account of issues such as the need
for corrections and the availability of new evidence.
Further work
Many organisations are now using explicit and systematic
priority setting processes for practice guidelines and
health technology assessments. A more comprehensive
and systematic survey of this experience could inform
decisions about processes WHO should use to set priori-
ties for recommendations. Because there is uncertainty
about the best ways to set priorities, the processes that are
used should be evaluated. When feasible and relevant,
alternative processes should be directly compared with
respect to the priorities that are generated and the
resources that are used.
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